In a previous study, luteolin has been used in the treatment of COPD, the mechanism of which is associated with the regulation of epidermal growth factor receptor, matrix metallopeptidase 9, and so forth.47 This evidence concerns the gene MMP9 and chronic obstructive pulmonary disease.